Thursday, 23 May 2019

Shanghai Kinetic to acquire Elliquence for $77 M

13 June 2018 | News

About 52 per cent of Elliquence's revenues are from China.

Image credit-

Image credit-

Shanghai Kinetic Medical Co recently announced that it plans to take over US medical technology company Elliquence LLC for $77.15 million.

Elliquence makes radiofrequency products that are used in minimally invasive orthopedic surgeries, especially for disc herniation and intervertebral disc tear.

About 52 per cent of Elliquence's revenues are from China. Kinetic Medical, which plans to gradually take over distribution of Elliquence's products, also makes minimally invasive surgical systems, especially for orthopedic surgeries, plus orthopedic implants and stents.

Elliquence CEO Alan Ellman will remain responsible for the US and international businesses after the deal.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls